gatifloxacin has been researched along with Nearsightedness in 4 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eyes treated with moxifloxacin healed faster and had smaller defects compared with those treated with gatifloxacin." | 2.71 | The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy. ( Bower, KS; Burka, JM; Howard, RS; Kuzmowych, CP; Stutzman, RD; Vanroekel, RC, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burka, JM | 1 |
| Bower, KS | 1 |
| Vanroekel, RC | 1 |
| Stutzman, RD | 1 |
| Kuzmowych, CP | 1 |
| Howard, RS | 1 |
| Moshirfar, M | 1 |
| Mirzaian, G | 1 |
| Feiz, V | 1 |
| Kang, PC | 1 |
| de la Cruz, J | 1 |
| Behlau, I | 1 |
| Pineda, R | 1 |
| Ursea, R | 1 |
| Purcell, TL | 1 |
| Tan, BU | 1 |
| Nalgirkar, A | 1 |
| Lovaton, ME | 1 |
| Ehrenhaus, MR | 1 |
| Schanzlin, DJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Clinical Trial Comparing the Effect of Moxifloxacin Versus Gatifloxacin Following Pterygium Excision on Corneal Epithelial Healing and Epithelial Toxicity.[NCT00892918] | 40 participants (Anticipated) | Interventional | 2009-06-30 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for gatifloxacin and Nearsightedness
| Article | Year |
|---|---|
The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy.
Topics: Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Astigmatism; Aza Compounds; Double-Blind Metho | 2005 |
3 other studies available for gatifloxacin and Nearsightedness
| Article | Year |
|---|---|
Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery.
Topics: Adult; Aza Compounds; Bacteria; Cornea; Corneal Ulcer; Drug Resistance, Bacterial; Drug Therapy, Com | 2006 |
Atypical mycobacteria keratitis after laser in situ keratomileusis unresponsive to fourth-generation fluoroquinolone therapy.
Topics: Adult; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Eye Infections, Bacterial; | 2007 |
The effect of cyclosporine A (Restasis) on recovery of visual acuity following LASIK.
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Astigmatism; Cyclosporine; Drug Therapy | 2008 |